Development of a Novel Clinical Decision Support System for Exercise Prescription Among Patients With Multiple Cardiovascular Disease Risk Factors.
Linda S Pescatello, Yin Wu, Gregory A Panza...
https://pubmed.ncbi.nlm.nih.gov/33718793/Actively Recruiting
Led by University of Connecticut · Updated on 2026-08-12
72
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are conducting a randomized controlled trial to assess a new digital health tool called Prioritize Personalize Prescribe EXercise P3-EX. This tool is designed to help physicians prescribe personalized exercise programs to adults with cardiovascular disease CVD risk factors such as obesity, hypertension, dyslipidemia, and diabetes. The trial aims to test the usability and satisfaction of P3-EX compared to a generic exercise prescription method called the American College of Sports Medicine Physical Activity Vital Sign ACSM-PAVS. In the study, 24 physicians will each recruit two patients with CVD risk factors, assigning one patient to receive an exercise prescription via P3-EX and the other to receive the ACSM-PAVS prescription in a randomized crossover design. Patients will follow their prescribed exercise programs unsupervised for 12 weeks, with virtual weekly oversight from University of Connecticut Graduate Research Assistants. The P3-EX tool uses cardiovascular health scoring and tailored exercise recommendations based on the patients highest risk factors, while ACSM-PAVS provides a general exercise guideline. Patients will record their exercise using a self-report diary, and receive exercise guidance through virtual visits and weekly emails. Throughout the 12 weeks, patients will attend in-person visits before and after the intervention to assess CVD risk factors, physical activity levels using accelerometers, and satisfaction with the exercise programs. Physicians and patients will complete usability questionnaires shortly after exercise prescription delivery to evaluate feasibility and acceptability. The study will also analyze changes in cardiovascular health markers, exercise adherence, and physical activity to explore preliminary efficacy. The total participation includes initial assessments, 12-week exercise monitoring with virtual support, and follow-up evaluations.
CONDITIONS
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
A
Alexander J Wright, MS
L
Linda S Pescatello, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Connecticut
Lead Sponsor
Hartford HealthCare
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | P3-EX Digital Prescription | ACSM-PAVS Exercise Prescription |
|---|---|---|
| What is it? | A structured, digitally supported exercise prescription system (P3-EX) delivered with virtual oversight, aiming to tailor exercise plans for sedentary adults with cardiovascular risk factors. | A standard exercise prescription approach using the American College of Sports Medicine Physical Activity Vital Sign (ACSM-PAVS) tool, delivered with equivalent virtual oversight. |
| Role in trial | Experimental intervention; receives digitally tailored exercise prescription via P3-EX. | Active comparator; receives standard guideline-based exercise prescription using ACSM-PAVS. |
| Primary use | To support clinicians in prescribing individualized exercise for adults with cardiovascular disease risk factors using a digital decision aid. | To guide clinicians in delivering exercise advice based on the ACSM physical activity recommendations. |
| How is it given or performed? | Participants receive an individualized 12-week unsupervised exercise program through the P3-EX digital system with virtual weekly follow-up by research staff, personalized exercise recommendations, and regular progress review. | Participants receive a 12-week unsupervised exercise program based on ACSM-PAVS principles, with equivalent virtual oversight, generic exercise advice, and regular check-ins by research staff. |
| Evidence status | Evidence on feasibility and acceptability in this population is emerging. Wider effectiveness and patient outcome data are not yet established, and ongoing research is assessing the clinical value. | Supported by established exercise guidelines and research as a valid framework for assessing and promoting physical activity in adults with cardiovascular risk factors. Effectiveness in improving physical activity and cardiovascular health is supported by prior evidence. |
| Important limitations | Requires digital access and basic technology skills. The algorithm is still investigational; long-term effectiveness, safety, and real-world adoption for diverse populations remain under study. | Standardized advice may not account for individual needs or barriers. Does not offer digital decision-support or individualized exercise recommendations, which could limit engagement or adherence in some adults. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
2 in-person visits
Duration - 12 weeks
Participants receive either the P3-EX personalized exercise prescription or the ACSM-PAVS standard exercise program from their physician. They follow their assigned 12-week unsupervised exercise plan with virtual weekly support and record their exercise using diaries and virtual visits.
Weekly virtual check-ins and two virtual guidance visits
Duration - Within 1 week after intervention
Participants attend in-person visits to assess cardiovascular risk factors, physical activity levels, and satisfaction with the exercise program after completing the intervention.
2 in-person visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Linda S Pescatello, Yin Wu, Gregory A Panza...
https://pubmed.ncbi.nlm.nih.gov/33718793/Amanda L Zaleski, Rachel Berkowsky, Kelly Jean Thomas Craig...
https://pubmed.ncbi.nlm.nih.gov/38206661/Shiqi Chen, Yin Wu, Erica L Bushey...
https://pubmed.ncbi.nlm.nih.gov/38132645/Alexander J Wright, Gregory A Panza, Antonio B Fernandez...
https://pubmed.ncbi.nlm.nih.gov/41595324/Shiqi Chen, Yin Wu, Justin Kennedy...
https://pubmed.ncbi.nlm.nih.gov/40677518/University of Connecticut
Lead Sponsor
Hartford HealthCare
Collaborating Sponsor